BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28365035)

  • 1. Efficacy of Varenicline for Cigarette Reduction Before Quitting in Japanese Smokers: A Subpopulation Analysis of the Reduce to Quit Trial.
    Nakamura M; Abe M; Ohkura M; Treadow J; Yu CR; Park PW
    Clin Ther; 2017 Apr; 39(4):863-872. PubMed ID: 28365035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.
    Ebbert JO; Hughes JR; West RJ; Rennard SI; Russ C; McRae TD; Treadow J; Yu CR; Dutro MP; Park PW
    JAMA; 2015 Feb; 313(7):687-94. PubMed ID: 25688780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
    Tsai ST; Cho HJ; Cheng HS; Kim CH; Hsueh KC; Billing CB; Williams KE
    Clin Ther; 2007 Jun; 29(6):1027-39. PubMed ID: 17692719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
    Nakamura M; Oshima A; Fujimoto Y; Maruyama N; Ishibashi T; Reeves KR
    Clin Ther; 2007 Jun; 29(6):1040-56. PubMed ID: 17692720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.
    Xenakis JG; Kinter ET; Ishak KJ; Ward AJ; Marton JP; Willke RJ; Davies S; Caro JJ
    Pharmacoeconomics; 2011 Jun; 29(6):497-510. PubMed ID: 21452908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of lapse and relapse to smoking in successful quitters in a varenicline post hoc analysis in Japanese smokers.
    Nakamura M; Oshima A; Ohkura M; Arteaga C; Suwa K
    Clin Ther; 2014 Jun; 36(6):918-27. PubMed ID: 24811751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
    Evins AE; Cather C; Pratt SA; Pachas GN; Hoeppner SS; Goff DC; Achtyes ED; Ayer D; Schoenfeld DA
    JAMA; 2014 Jan; 311(2):145-54. PubMed ID: 24399553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
    Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
    JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
    Ebbert JO; Hatsukami DK; Croghan IT; Schroeder DR; Allen SS; Hays JT; Hurt RD
    JAMA; 2014 Jan; 311(2):155-63. PubMed ID: 24399554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
    Nollen NL; Ahluwalia JS; Sanderson Cox L; Okuyemi K; Lawrence D; Samuels L; Benowitz NL
    JAMA Netw Open; 2021 Jan; 4(1):e2032053. PubMed ID: 33464316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Extending the Duration of Prequit Treatment With Varenicline on Smoking Abstinence: A Randomized Clinical Trial.
    Hawk LW; Tiffany ST; Colder CR; Ashare RL; Wray JM; Tyndale RF; Brandon TH; Mahoney MC
    JAMA Netw Open; 2022 Nov; 5(11):e2241731. PubMed ID: 36367720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
    King A; Vena A; de Wit H; Grant JE; Cao D
    JAMA Netw Open; 2022 Mar; 5(3):e220951. PubMed ID: 35244704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial.
    Hurt RT; Ebbert JO; Croghan IT; Schroeder DR; Hurt RD; Hays JT
    Drug Alcohol Depend; 2018 Mar; 184():12-17. PubMed ID: 29324248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Russo C; Walicka M; Caponnetto P; Cibella F; Maglia M; Alamo A; Campagna D; Frittitta L; Di Mauro M; Caci G; Krysinski A; Franek E; Polosa R
    JAMA Netw Open; 2022 Jun; 5(6):e2217709. PubMed ID: 35727580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of varenicline in achieving abstinence among waterpipe tobacco smokers - study protocol for a randomized controlled trial.
    Zahid R; Dogar O; Mansoor S; Khan A; Kanaan M; Jawad M; Ahluwalia JS; Siddiqi K
    Trials; 2017 Jan; 18(1):14. PubMed ID: 28077163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
    Tonstad S
    J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial.
    Fagerström K; Gilljam H; Metcalfe M; Tonstad S; Messig M
    BMJ; 2010 Dec; 341():c6549. PubMed ID: 21134997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.